Mona Ashiya - 11 Jun 2025 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Director
Issuer ticker: IRON
Reported as of: 11 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jun 2025, 17:10:06 UTC
Prior SEC filing: 26 Mar 2025
Next SEC filing: 02 Sep 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

Mona Ashiya filed Form 4 for Disc Medicine, Inc. (IRON) on 13 Jun 2025.

Key facts

This page summarizes Mona Ashiya's Form 4 filing for Disc Medicine, Inc. (IRON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2025, 17:10.

Change

Previous filing in this sequence was filed on 26 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001794070 Primary reporting owner

Ashiya Mona

Relationship: Director
Address: C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101, WATERTOWN
Signature: By: /s/ Rahul Khara, as Attorney-in-Fact
Signature date: 13 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 11 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $50.86
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2026 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date.

Footnote F2

Pursuant to an agreement with OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, and OrbiMed Capital GP VIII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, and OrbiMed Capital GP VIII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP and OrbiMed Private Investments VIII, LP.